1. Home
  2. DVA vs WIX Comparison

DVA vs WIX Comparison

Compare DVA & WIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • WIX
  • Stock Information
  • Founded
  • DVA 1994
  • WIX 2006
  • Country
  • DVA United States
  • WIX Israel
  • Employees
  • DVA N/A
  • WIX N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • WIX Computer Software: Programming Data Processing
  • Sector
  • DVA Health Care
  • WIX Technology
  • Exchange
  • DVA Nasdaq
  • WIX Nasdaq
  • Market Cap
  • DVA 12.2B
  • WIX 10.4B
  • IPO Year
  • DVA 1995
  • WIX 2013
  • Fundamental
  • Price
  • DVA $165.51
  • WIX $217.20
  • Analyst Decision
  • DVA Hold
  • WIX Strong Buy
  • Analyst Count
  • DVA 5
  • WIX 17
  • Target Price
  • DVA $153.40
  • WIX $209.53
  • AVG Volume (30 Days)
  • DVA 1.0M
  • WIX 641.7K
  • Earning Date
  • DVA 10-29-2024
  • WIX 11-20-2024
  • Dividend Yield
  • DVA N/A
  • WIX N/A
  • EPS Growth
  • DVA 41.03
  • WIX N/A
  • EPS
  • DVA 9.24
  • WIX 1.60
  • Revenue
  • DVA $12,666,614,000.00
  • WIX $1,703,966,000.00
  • Revenue This Year
  • DVA $6.17
  • WIX $13.72
  • Revenue Next Year
  • DVA $3.56
  • WIX $14.02
  • P/E Ratio
  • DVA $17.90
  • WIX $135.92
  • Revenue Growth
  • DVA 6.34
  • WIX 12.63
  • 52 Week Low
  • DVA $98.26
  • WIX $95.65
  • 52 Week High
  • DVA $168.50
  • WIX $220.22
  • Technical
  • Relative Strength Index (RSI)
  • DVA 62.72
  • WIX 78.37
  • Support Level
  • DVA $154.05
  • WIX $175.06
  • Resistance Level
  • DVA $161.80
  • WIX $220.22
  • Average True Range (ATR)
  • DVA 4.24
  • WIX 7.32
  • MACD
  • DVA 1.71
  • WIX 4.43
  • Stochastic Oscillator
  • DVA 96.71
  • WIX 94.73

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

About WIX Wix.com Ltd.

Wix.com is a software-as-a-service content management system platform that allows users to create, customize, and manage websites for themselves, or for clients. Wix is best known for its Wix Editor service for self-creators, but in recent years has invested heavily and introduced its Wix Studio offering for partners, who are agencies and developers. Wix also offers a range of business solutions such as payment services and marketing products.

Share on Social Networks: